Breast Cancer Grand Round with Dr Rachel Joyce
Towards non-invasive chemoprevention for at-risk patients
Wednesday 13 November 12.30-1.30pm
Dr Rachel Joyce will discuss the identification of cells - aberrant luminal progenitors - as cells-of-origin in BRCA2 breast cancer, and the discovery of a novel prevention target for people who carry this genetic change.